Press Releases
Home > About Astellas > Astellas News > Press Releases
2013
- Janeway receives a new Starlight Fun Centre on behalf of Astellas to bring joy to children with serious illnesses
- May 22, 2013
- Astellas introduces Myrbetriq, a new class of treatment for Canadian patients with overactive bladder
- April 10, 2013
- There's a little Picasso in all of us: EASE announces the winners to its fourth annual "My Life with Eczema" art contest
- March 19, 2013
- Astellas Pharma Canada, Inc. receives a Notice of Compliance from Health Canada for Myrbetriq (mirabegron)
- March 8, 2013
2012
- Urology research grant focused on improving patient care
- December 12, 2012
- For Men with Prostate Cancer, Sex Still Matters
- November 29, 2012
- Can Women Get Prostate Cancer? 34 per cent of Canadians confuse prostate cancer as a disease that can affect both men and women
- September 17, 2012
- Canadian urology research gets a boost
- August 28, 2012
- Medivation and Astellas Announce Positive Results from the Phase 3 AFFIRM Trial of MDV3100 in Prostate Cancer Patients Who Received Prior Chemotherapy
- February 1, 2012
- Astellas announces new Vice President of Sales and Marketing
- January 26, 2012
- Astellas and Theravance Announce Termination of License, Development and Commercialization Agreement for VIBATIV® (telavancin) for Injection
- January 10, 2012
2011
- Lawsuit Against Sandoz For Patent Litigation In Canada
- July 14, 2011
- Astellas Assesses the Impact of the Tohoku Earthquake
- March 15, 2011
- Health Canada approves Protopic® (tacrolimus ointment) for the prevention of eczema flares.
- February 17, 2011
- Youngsters Illustrate What Eczema Feels Like Through Their Art
- February 14, 2011
2010
- Astellas Pharma Canada Employees Participate in First Annual 'Changing Tomorrow Day'
- October 19, 2010
- Astellas Pharma Canada Appoints New President
- June 29, 2010
- Canadian Children Splash New Colours on Red, Itchy Skin
- February 4, 2010
2009
- Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications
- December 18, 2009
- Give Your Bladder a Hug This Month
- November 23, 2009
- Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer
- October 27, 2009
- Famous Cartoonist Helps EASE Program Select the Next Pablo Picasso
- September 29, 2009
- Powder Room Gives its Summer Road Trip Seal of Approval
- June 22, 2009
- Solifenacin shows superior tolerability compared to oxybutynin immediate-release (IR)
- April 30, 2009
- Financial woes may worsen eczema symptoms
- February 5, 2009
2008
- The Powder Room: Keeping In Better Shape Below The Belt
- November 4, 2008
- Ease into Back-To-School: Program Helps Kids with Eczema Learn the ABCs of Managing Their Condition
- August 28, 2008
- "Canada's Best Restrooms Honoured" - The Powder Room Seal Of Approval Awarded Nationwide
- June 25, 2008
- AdvagrafTM (Extended Release Tacrolimus) is Now Available In Canada for Kidney Transplant Patients
- April 15, 2008
- Join The Search For Canada's Best Restrooms: Education Program Launches Cross-Canada Powder Room Map
- March 6, 2008
2007
- Astellas Pharma announces the availability of Mycamine® in Canada
- October 17, 2007
- What Happens in The Powder Room, Stays in The Powder Room
- October 2, 2007
- Health Canada approves Astellas' Mycamine®
- June 1, 2007
2006
- VesicareTM (Solefinacin Succinate) Now Available in Canada
- November 16, 2006
- Astellas to Acquire AMEVIVE®
- April 3, 2006
- Rub-A-Dub-Dub! Spend time in the tub!
- April 3, 2006
2005
- Introducing "Penny's EGGS-im-ah"
- September 12, 2005
- Yamanouchi, Fujisawa Unite to Form Astellas Pharma - Canadian operation based in Markham, Ontario
- April 1, 2005
- Fujisawa Canada donates two paediatric dermatology fellowships
- February 28, 2005
Site Map | Privacy Policy | Legal Disclaimer | Contact Us© 2011 Astellas Pharma Canada, Inc. All Rights Reserved.